Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Computers in Biology and Medicine
- Vol. 128, 104124
- https://doi.org/10.1016/j.compbiomed.2020.104124
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Peptidomimetics, a synthetic tool of drug discoveryCurrent Opinion in Chemical Biology, 2008
- HIV-1 Protease Substrate Binding and Product Release Pathways Explored with Coarse-Grained Molecular DynamicsBiophysical Journal, 2007
- Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunityTissue Antigens, 2004
- Identification of an Antigenic Determinant on the S2 Domain of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Capable of Inducing Neutralizing AntibodiesJournal of Virology, 2004
- Beyond proteinsTrends in Biotechnology, 1999
- Doppelgänger proteins as drug leadsNature Biotechnology, 1996
- Self‐organizing hierarchic networks for pattern recognition in protein sequenceProtein Science, 1996
- The interpretation of protein structures: Estimation of static accessibilityJournal of Molecular Biology, 1971
- CULTIVATION OF VIRUSES FROM A HIGH PROPORTION OF PATIENTS WITH COLDSThe Lancet, 1966
- A New Virus Isolated from the Human Respiratory Tract.Experimental Biology and Medicine, 1966